Cindy Cao, Ph.D., has over twenty years of drug discovery and development experience in pharmaceutical and biotech companies and has extensive expertise in global and US regulatory strategy and policy on biologics. Dr. Cao holds a B.S. in Genetics from Fudan University, a Ph.D. in Biomedical Sciences from the University of New Mexico, and completed an NIH-sponsored post-doctoral fellowship at the University of Utah.
Org chart
No direct reports
Teams
Offices
This person is not in any offices
H
Humacyte
1 followers
Humacyte, Inc., is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine.
